SRI Krishna Pharmaceuticals Limited — Amino Exporter Profile
Indian Pharmaceutical Exporter · #3 for Amino · $7.8M export value · DGFT Verified
SRI Krishna Pharmaceuticals Limited is the #3 Indian exporter of Amino with $7.8M in export value and 155 verified shipments. SRI Krishna Pharmaceuticals Limited holds a 2.4% market share in Amino exports across 7 countries. The company exports 6 pharmaceutical products worth $31.4M across 3 therapeutic categories.
SRI Krishna Pharmaceuticals Limited — Amino Export Profile: Buyers & Destinations

Where Does SRI Krishna Pharmaceuticals Limited Export Amino?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $3.6M | 81 | 54.0% |
| MEXICO | $2.7M | 61 | 40.9% |
| ECUADOR | $198.1K | 6 | 3.0% |
| SPAIN | $50.0K | 1 | 0.8% |
| CHILE | $43.1K | 4 | 0.7% |
| VENEZUELA | $32.5K | 1 | 0.5% |
| VIETNAM | $7.4K | 1 | 0.1% |
SRI Krishna Pharmaceuticals Limited exports Amino to 7 countries. The largest destination is CANADA accounting for 54.0% of SRI Krishna Pharmaceuticals Limited's Amino shipments, followed by MEXICO (40.9%) and ECUADOR (3.0%). These destinations reflect SRI Krishna Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amino from SRI Krishna Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MARCAN PHARMACEUTICALS INC., | CANADA | $1.1M | 31 |
| TO HELM DE | MEXICO | $646.0K | 16 |
| HELM DE MEXICO, S.A. | MEXICO | $250.0K | 5 |
| TO MARCAN PHARAMACEUTICALS | CANADA | $150.0K | 3 |
| TO MARCAN PHARAMACEUTICALS INC | CANADA | $150.0K | 3 |
| HELM DE MEXICO S A | MEXICO | $150.0K | 3 |
| TO IMCD CANADA LIMITED | CANADA | $100.0K | 2 |
| MARCAN PHARMACEUTICALS INC | CANADA | $100.0K | 2 |
| MARCAN PHARMACEUTICAL INC | CANADA | $100.0K | 2 |
| TO, | MEXICO | $78.1K | 5 |
SRI Krishna Pharmaceuticals Limited supplies Amino to 18 buyers globally. The largest buyer is MARCAN PHARMACEUTICALS INC., (CANADA), followed by TO HELM DE (MEXICO) and HELM DE MEXICO, S.A. (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amino Export Value and How Much Does SRI Krishna Pharmaceuticals Limited Contribute?
India exported $177.9M worth of Amino through 8,996 shipments from 635 suppliers to 161 countries, serving 1,400 buyers globally. SRI Krishna Pharmaceuticals Limited contributes $7.8M to this total, accounting for 2.4% of India's Amino exports. SRI Krishna Pharmaceuticals Limited ships Amino to 7 countries through 18 buyers.
What Is the Average Shipment Value for SRI Krishna Pharmaceuticals Limited's Amino Exports?
SRI Krishna Pharmaceuticals Limited's average Amino shipment value is $50.0K per consignment, based on 155 shipments totaling $7.8M. The largest destination is CANADA (54.0% of SRI Krishna Pharmaceuticals Limited's Amino exports).
How Does SRI Krishna Pharmaceuticals Limited Compare to Other Indian Amino Exporters?
SRI Krishna Pharmaceuticals Limited ranks #3 among 635 Indian Amino exporters with a 2.4% market share. The top 3 exporters are GRANULES INDIA LIMITED ($85.0M), ELYSIUM PHARMACEUTICALS LTD ($19.6M), OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED ($14.0M). SRI Krishna Pharmaceuticals Limited processed 155 shipments to 7 destination countries.
What Amino Formulations Does SRI Krishna Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Acetaminophen SR tablets USP 650mg- Bulk | $400.0K | 8 |
| PARACETAMOL GRANULES DC GRADE (ACETAMINO | $328.1K | 10 |
| PARACETAMOL GRANULES DC GRADE(ACETAMINOP | $250.0K | 5 |
| PARACETAMOL GRANULES DC GRADE 90% (ACETAMINOPHEN GRANULES DC 90%) | $250.0K | 5 |
| ACETAMINOPHEN SR TABLETS USP 650MG- BULK | $200.0K | 4 |
| Acetaminophen SR tablets USP 650mg -Bulk | $150.0K | 3 |
| PARACETAMOL GRANULES DC GRADE ACETAMINOPHEN GRANULES DC 90%[KRISOPAP-90C] | $150.0K | 3 |
| PARACETAMOL GRANULES DC GRADE( ACETAMINOPHEN GRANULES DC 90%)[KRISOPAP-90C]KGS | $150.0K | 3 |
| PARACETAMOL GRANULES DC GRADE 90 ACETAMINOPHEN GRANULES DC 90 | $150.0K | 3 |
| PARACETAMOL GRANULES DC GRADE(ACETAMINOPHEN GRANULES DC 90%)[KRISOPAP-90C]KGS | $145.6K | 3 |
SRI Krishna Pharmaceuticals Limited exports 86 distinct Amino formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Acetaminophen SR tablets USP 650mg- Bulk with 8 shipments worth $400.0K.
Regulatory Requirements: Exporting Amino to Key Markets
What SRI Krishna Pharmaceuticals Limited must comply with to export Amino to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SRI Krishna Pharmaceuticals Limited Compare to Nearest Amino Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED | $14.0M | 288 | 27 | $48.5K |
| 6 | MARKSANS PHARMA LIMITED | $12.5M | 540 | 3 | $23.2K |
| 3 | SRI KRISHNA PHARMACEUTICALS LIMITED ★ | $7.8M | 155 | 7 | $50.0K |
| 5 | PHAROSE REMEDIES LIMITED | $6.2M | 124 | 4 | $50.0K |
| 9 | MYLAN LABORATORIES LIMITED | $6.1M | 211 | 2 | $28.8K |
SRI Krishna Pharmaceuticals Limited ranks #3 among 635 Indian Amino exporters. Average shipment value of $50.0K compared to the market average of $280.2K. The closest competitors by value are OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED and MARKSANS PHARMA LIMITED.
Which Indian Ports Ship Amino Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 739 | 8.2% |
| HYDERABAD ICD | 698 | 7.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 633 | 7.0% |
| HYDERABAD ICD (INSNF6) | 574 | 6.4% |
| SAHAR AIR | 548 | 6.1% |
| JNPT/ NHAVA SHEVA SEA | 418 | 4.6% |
| MUNDRA SEA | 417 | 4.6% |
| MUNDRA SEA (INMUN1) | 364 | 4.0% |
Geopolitical & Trade Policy Impact on SRI Krishna Pharmaceuticals Limited's Amino Exports
Recent geopolitical tensions, notably the Israel-Iran conflict, have disrupted key shipping routes such as the Red Sea, leading to increased freight costs and extended transit times for Indian pharmaceutical exporters. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has highlighted potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. For SKPL, which relies on timely deliveries to maintain product efficacy, these logistical challenges necessitate strategic adjustments, including exploring alternative shipping routes and bolstering regional distribution networks.
In the US market, recent tariff implementations have introduced additional complexities for Indian exporters. While generic drugs have been exempted from certain tariffs, the overall trade environment remains uncertain. SKPL must remain vigilant, monitoring policy shifts and adapting its export strategies accordingly to maintain its competitive edge.
The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, presents new opportunities for SKPL in European markets. By eliminating or reducing tariffs on pharmaceutical products, the agreement facilitates smoother market entry, allowing SKPL to expand its footprint in EFTA member countries.
SRI Krishna Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with bodies like the US FDA increasing inspections to ensure compliance with Good Manufacturing Practices (GMP). India, hosting over 600 US FDA-approved manufacturing sites, faces ongoing challenges in maintaining consistent quality standards. Instances of substandard products have prompted calls for stricter oversight. For SKPL, maintaining rigorous quality control measures and staying abreast of evolving regulatory requirements are imperative to sustain its export credentials and market reputation.
About SRI Krishna Pharmaceuticals Limited
SRI Krishna Pharmaceuticals Limited exports 6 products worth $31.4M. Beyond Amino, top products include Paracetamol, Acetaminophen, Tramadol, Loperamide, Aspirin. View the complete SRI Krishna Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amino — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amino shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SRI Krishna Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 155 individual customs records matching SRI Krishna Pharmaceuticals Limited exporting Amino, covering 86 formulations to 7 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 161+ countries, 1,400+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amino Export Data from SRI Krishna Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SRI Krishna Pharmaceuticals Limited's Amino exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SRI Krishna Pharmaceuticals Limited
Full Company Profile →
6 products · $31.4M total trade · 3 categories
Amino Stats
Company Overview
Top Products by SRI Krishna Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SRI Krishna Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amino. For current shipment-level data, contact TransData Nexus.